PremiumCompany AnnouncementsAtomo Diagnostics Launches $1 Million Security Purchase Plan Atomo Diagnostics Announces Change in Substantial Shareholding Atomo Diagnostics Announces Director Resignation PremiumCompany AnnouncementsAtomo Diagnostics Expands HIV Self-Test Market and Secures Syphilis Test License Atomo Diagnostics Announces Proposed Securities Issue to Boost Capital Atomo Diagnostics Completes $3.1 Million Capital Raise and Announces Restructuring PremiumCompany AnnouncementsAtomo Diagnostics Faces Suspension from ASX Quotation Atomo Diagnostics Releases H1 FY2025 Results with Cautionary Notes Atomo Diagnostics Reports Revenue Growth Amid Reduced Losses